Cardiac Biomarker Company Critical Diagnostics Completes $8.5 Million Financing and Announces Two Promotions

PRESS RELEASE: Critical Diagnostics, makers of the Presage® ST2 Assay and ASPECT-PLUSTM ST2 Test, both used to help physicians in the management of heart failure patients, today announced it completed an $8.5 million equity financing from...